Saturday 17 October 2026
Export ADUS’s income statement to Excel — free account
Addus HomeCare Corporation
ADUS Healthcare Medical Care Facilities
Addus HomeCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 23.2% from fiscal 2024. In the quarter to June 2026, revenue grew 8.01%, EPS grew 24.2%, free cash flow grew 81.7% and total debt fell 63.6%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
116.05
0.44
−0.38%
Follow ADUS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
25.27 | 20.61 | 17.31 | 17.63 |
P/S ratio |
1.58 | 1.36 | 1.18 | 1.24 | |
P/FCF ratio |
22.15 | 18.70 | 12.41 | 11.88 | |
P/Operating CF |
41.59 | 103.33 | 32.54 | 45.93 | |
P/B ratio |
2.03 | 1.79 | 1.53 | 1.60 | |
Price to Tangible BV |
0.00 | 0.00 | 89.72 | 45.15 | |
EV/Sales |
1.62 | 1.39 | 1.17 | 1.22 | |
EV/EBITDA |
15.57 | 12.66 | 10.58 | 10.83 | |
EV/Operating CF |
21.15 | 17.75 | 11.68 | 11.09 | |
EV/FCF |
22.67 | 19.09 | 12.33 | 11.64 | |
Quick Ratio |
1.50 | 1.56 | 1.66 | 1.46 | |
Current Ratio |
1.66 | 1.80 | 1.83 | 1.69 | |
Net Debt/EBITDA |
1.29 | 0.84 | (0.31) | (0.87) | |
Debt/Assets |
10.59% | 8.42% | 6.36% | 4.23% | |
Debt/Equity |
0.14 | 0.11 | 0.08 | 0.05 | |
Asset Turnover |
1.05 | 1.00 | 1.02 | 1.03 | |
Operating CF/Net income |
2.24 | 0.63 | 2.09 | 1.45 | |
Capex/Depreciation |
(0.41) | (0.59) | (0.39) | (0.30) | |
Interest Coverage |
9.85 | 15.51 | 15.84 | 22.59 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
21.91% | 20.69% | 21.39% | 20.80% | |
Intangible Assets out of Total Assets |
0.77 | 0.76 | 0.76 | 0.76 | |
Share Based Compensation of Revenue |
1.18% | 1.22% | 1.38% | 1.16% | |
Graham Net Nets |
(0.05) | (0.04) | (0.03) | (0.01) | |
Graham Number |
78.13 | 83.95 | 86.42 | 89.72 | |
Earnings Yield |
3.96% | 4.85% | 5.78% | 5.67% | |
Free Cash Flow Yield |
4.51% | 5.35% | 8.06% | 8.42% | |
Revenue per Share |
20.05 | 20.67 | 19.99 | 20.63 | |
Operating CF per Share |
2.84 | 1.04 | 2.88 | 2.19 | |
Capex per Share |
(0.11) | (0.15) | (0.09) | (0.07) | |
Free Cash Flow per Share |
2.73 | 0.89 | 2.79 | 2.12 | |
Cash per Share |
5.64 | 4.52 | 5.66 | 5.44 | |
Shareholders Equity per Share |
58.10 | 60.12 | 61.35 | 62.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
58.10 | 60.12 | 61.35 | 62.77 | |
Free Cash Flow |
49.34 | 16.11 | 50.67 | 38.69 | |
Working Capital |
103.86 | 120.00 | 123.40 | 116.00 | |
Capital Expenditures |
(1.93) | (2.66) | (1.69) | (1.32) | |
Net Current Asset Value |
(112.30) | (82.51) | (46.66) | (24.18) | |
EV/EBIT |
17.70 | 14.28 | 11.91 | 12.15 | |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.00 | |
Price to Operating Income |
17.30 | 13.99 | 11.98 | 12.40 | |
| Other line items | |||||
Average Receivables |
115.33 | 137.29 | 139.72 | 142.61 | |
Average Payables |
22.20 | 22.00 | 21.00 | 16.86 | |
Average Assets |
1,287.92 | 1,424.97 | 1,421.64 | 1,432.71 | |
Average Common Equity |
998.80 | 1,027.90 | 1,055.77 | 1,085.01 |
Columns are period end dates